Literature DB >> 13887179

The enhancement of chloroform-induced plasma proteolytic activity by epsilon aminocaproic acid.

V H DONALDSON, O D RATNOFF.   

Abstract

The proteolytic activity in chloroform-treated plasma euglobulins has been attributed to plasmin. Plasmin can digest both casein and fibrin. Epsilon aminocaproic acid, which inhibits the activation of plasminogen, the precursor of plasmin, by streptokinase, urokinase, and tissue activators enhanced the development of casein hydrolytic activity in a mixture of chloroform and plasma euglobulins. Fibrinolytic activity was also enhanced, but this was evident only if the epsilon aminocaproic acid was removed from the chloroform-treated euglobulins prior to assay. The reasons for the paradoxical enhancement of chloroform-induced casein hydrolysis by euglobulins containing epsilon aminocaproic acid are unclear. However, studies of optimal pH, heat stability, and the effect of ionic strength on the activation of the precursor of this proteolytic enzyme do not differentiate it from plasminogen.

Entities:  

Keywords:  AMINO ACIDS/pharmacology; CHLOROFORM/pharmacology; PROTEASES/blood

Mesh:

Substances:

Year:  1962        PMID: 13887179      PMCID: PMC2137524          DOI: 10.1084/jem.115.4.695

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  xi-Aminocaproic acid: an inhibitor of plasminogen activation.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Biol Chem       Date:  1959-04       Impact factor: 5.157

2.  Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by 6-aminocaproic acid.

Authors:  F B ABLONDI; J J HAGAN; M PHILIPS; E C DE RENZO
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

3.  Physiologic and pathologic effects of increased fibrinolytic activity in man. With notes on the effects of exercise and certain inhibitors on fibrinolysis.

Authors:  O D RATNOFF; V H DONALDSON
Journal:  Am J Cardiol       Date:  1960-08       Impact factor: 2.778

4.  Purification and biochemical properties of human plasminogen.

Authors:  J J HAGAN; F B ABLONDI; E C DE RENZO
Journal:  J Biol Chem       Date:  1960-04       Impact factor: 5.157

5.  The multiplicity of plasmin inhibitors in human serum, demonstrated by the effect of primary amino compounds.

Authors:  O D RATNOFF; I H LEPOW; L PILLEMER
Journal:  Bull Johns Hopkins Hosp       Date:  1954-04

6.  Fibrinokinase.

Authors:  T ASTRUP
Journal:  Acta Physiol Scand       Date:  1951

7.  Partial purification and properties of a proteolytic enzyme of human serum.

Authors:  L F REMMERT; P P COHEN
Journal:  J Biol Chem       Date:  1949-11       Impact factor: 5.157

8.  Studies of the plasmin system. I. Measurement of human and animal plasminogen; measurement of an activator in human serum.

Authors:  P S NORMAN
Journal:  J Exp Med       Date:  1957-09-01       Impact factor: 14.307

9.  Studies on a proteolytic enzyme in human plasma; some factors influencing the enzymes activated by chloroform and by filtrates coccal fibrinolysin.

Authors:  O D RATNOFF
Journal:  J Exp Med       Date:  1948-03-01       Impact factor: 14.307

10.  Studies on a proteolytic enzyme in human plasma; the probable identity of the enzymes activated by chloroform and by filtrates of cultures of beta hemolytic streptococci.

Authors:  O D RATNOFF
Journal:  J Exp Med       Date:  1948-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.